Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Minimising the risk of diabetes in patients with schizophrenia and bipolar disorder.

Chue P, Cheung R.

Int J Psychiatry Clin Pract. 2006;10(2):105-16. doi: 10.1080/13651500600579084.

PMID:
24940960
[PubMed]
2.

[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].

Saravane D, Feve B, Frances Y, Corruble E, Lancon C, Chanson P, Maison P, Terra JL, Azorin JM; avec le soutien institutionnel du laboratoire Lilly.

Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9. French.

PMID:
19748369
[PubMed - indexed for MEDLINE]
3.

Drug Class Review: Atypical Antipsychotic Drugs: Final Update 3 Report [Internet].

McDonagh M, Peterson K, Carson S, Fu R, Thakurta S.

Portland (OR): Oregon Health & Science University; 2010 Jul.

PMID:
21348048
[PubMed]
Books & Documents
4.

[Schizophrenia, diabetes mellitus and antipsychotics].

Gury C.

Encephale. 2004 Jul-Aug;30(4):382-91. Review. French.

PMID:
15538314
[PubMed - indexed for MEDLINE]
5.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
[PubMed - indexed for MEDLINE]
6.

Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.

Maher AR, Theodore G.

J Manag Care Pharm. 2012 Jun;18(5 Suppl B):S1-20. Review.

PMID:
22784311
[PubMed - indexed for MEDLINE]
Free Article
7.

Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder.

Citrome L, Holt RI, Walker DJ, Hoffmann VP.

Clin Drug Investig. 2011;31(7):455-82. doi: 10.2165/11589060-000000000-00000. Review.

PMID:
21495734
[PubMed - indexed for MEDLINE]
8.

Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study.

Guo JJ, Keck PE Jr, Corey-Lisle PK, Li H, Jiang D, Jang R, L'Italien GJ.

Pharmacotherapy. 2007 Jan;27(1):27-35.

PMID:
17192159
[PubMed - indexed for MEDLINE]
9.

Safety and tolerability of atypical antipsychotics in patients with bipolar disorder: prevalence, monitoring and management.

Chue P, Kovacs CS.

Bipolar Disord. 2003;5 Suppl 2:62-79. Review.

PMID:
14700015
[PubMed - indexed for MEDLINE]
10.

Do certain atypical antipsychotics increase the risk of diabetes? A critical review of 17 pharmacoepidemiologic studies.

Ramaswamy K, Masand PS, Nasrallah HA.

Ann Clin Psychiatry. 2006 Jul-Sep;18(3):183-94. Review.

PMID:
16923657
[PubMed - indexed for MEDLINE]
11.

[Conference report: Belgian consensus on metabolic problems associated with atypical antipsychotics].

De Nayer A, De Hert M, Scheen A, Van Gaal L, Peuskens J.

Encephale. 2007 Mar-Apr;33(2):197-202. French.

PMID:
17675915
[PubMed - indexed for MEDLINE]
12.

Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics.

Correll CU, Frederickson AM, Kane JM, Manu P.

Bipolar Disord. 2008 Nov;10(7):788-97. doi: 10.1111/j.1399-5618.2008.00625.x.

PMID:
19032710
[PubMed - indexed for MEDLINE]
13.

Risk of diabetes mellitus associated with atypical antipsychotic use among patients with bipolar disorder: A retrospective, population-based, case-control study.

Guo JJ, Keck PE Jr, Corey-Lisle PK, Li H, Jiang D, Jang R, L'Italien GJ.

J Clin Psychiatry. 2006 Jul;67(7):1055-61.

PMID:
16889448
[PubMed - indexed for MEDLINE]
14.

The implications of weight changes with antipsychotic treatment.

Sussman N.

J Clin Psychopharmacol. 2003 Jun;23(3 Suppl 1):S21-6. Review.

PMID:
12832946
[PubMed - indexed for MEDLINE]
15.

Atypical antipsychotics and glucose homeostasis.

Bergman RN, Ader M.

J Clin Psychiatry. 2005 Apr;66(4):504-14. Review.

PMID:
15816794
[PubMed - indexed for MEDLINE]
16.

Importance of open access to atypical antipsychotics for the treatment of schizophrenia and bipolar disorder: a European perspective.

Altamura AC, Armadoros D, Jaeger M, Kernish R, Locklear J, Volz HP.

Curr Med Res Opin. 2008 Aug;24(8):2271-82. doi: 10.1185/03007990802250056. Epub 2008 Jun 26.

PMID:
18588748
[PubMed - indexed for MEDLINE]
17.

Comparing tolerability of olanzapine in schizophrenia and affective disorders: a meta-analysis.

Moteshafi H, Zhornitsky S, Brunelle S, Stip E.

Drug Saf. 2012 Oct 1;35(10):819-36. doi: 10.2165/11631510-000000000-00000.

PMID:
22967188
[PubMed - indexed for MEDLINE]
18.

Aripiprazole in schizophrenia and schizoaffective disorder: A review.

Stip E, Tourjman V.

Clin Ther. 2010;32 Suppl 1:S3-20. doi: 10.1016/j.clinthera.2010.01.021. Review.

PMID:
20152550
[PubMed - indexed for MEDLINE]
19.

Metabolic syndrome in schizophrenia: a comparative study of antipsychotic-free/naïve and antipsychotic-treated patients from India.

Pallava A, Chadda RK, Sood M, Lakshmy R.

Nord J Psychiatry. 2012 Jun;66(3):215-21. doi: 10.3109/08039488.2011.621977. Epub 2011 Oct 24.

PMID:
22017264
[PubMed - indexed for MEDLINE]
20.

[Metabolic side effects of risperidone in early onset schizophrenia].

Goeb JL, Marco S, Duhamel A, Kechid G, Bordet R, Thomas P, Delion P, Jardri R.

Encephale. 2010 Jun;36(3):242-52. doi: 10.1016/j.encep.2009.10.008. Epub 2009 Dec 1. French.

PMID:
20620267
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk